Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Resistance to thromboembolism in PI3Kgamma-deficient mice.
Hirsch E, Bosco O, Tropel P, Laffargue M, Calvez R, Altruda F, Wymann M, Montrucchio G. Hirsch E, et al. Among authors: laffargue m. FASEB J. 2001 Sep;15(11):2019-21. doi: 10.1096/fj.00-0810fje. Epub 2001 Jul 9. FASEB J. 2001. PMID: 11511514
Tumour biology. Weakening link to colorectal cancer?
Barbier M, Attoub S, Calvez R, Laffargue M, Jarry A, Mareel M, Altruda F, Gespach C, Wu D, Lu B, Hirsch E, Wymann MP. Barbier M, et al. Among authors: laffargue m. Nature. 2001 Oct 25;413(6858):796. doi: 10.1038/35101660. Nature. 2001. PMID: 11677595 No abstract available.
Phosphoinositide 3-kinase gamma: a key modulator in inflammation and allergy.
Wymann MP, Björklöf K, Calvez R, Finan P, Thomast M, Trifilieff A, Barbier M, Altruda F, Hirsch E, Laffargue M. Wymann MP, et al. Among authors: laffargue m. Biochem Soc Trans. 2003 Feb;31(Pt 1):275-80. doi: 10.1042/bst0310275. Biochem Soc Trans. 2003. PMID: 12546701 Review.
Phosphoinositide 3-kinase signalling--which way to target?
Wymann MP, Zvelebil M, Laffargue M. Wymann MP, et al. Among authors: laffargue m. Trends Pharmacol Sci. 2003 Jul;24(7):366-76. doi: 10.1016/S0165-6147(03)00163-9. Trends Pharmacol Sci. 2003. PMID: 12871670 Review. No abstract available.
Genetic and pharmacological targeting of phosphoinositide 3-kinase-gamma reduces atherosclerosis and favors plaque stability by modulating inflammatory processes.
Fougerat A, Gayral S, Gourdy P, Schambourg A, Rückle T, Schwarz MK, Rommel C, Hirsch E, Arnal JF, Salles JP, Perret B, Breton-Douillon M, Wymann MP, Laffargue M. Fougerat A, et al. Among authors: laffargue m. Circulation. 2008 Mar 11;117(10):1310-7. doi: 10.1161/CIRCULATIONAHA.107.720466. Epub 2008 Feb 11. Circulation. 2008. PMID: 18268153
63 results